Skye Bioscience’s obesity candidate has failed to reduce weight in a phase 2 study, marking another setback for the CB1 inhibitor class. The biotech had been evaluating a 200-mg weekly subcutaneous ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Skye Bioscience said ...
Community Board 1 claims to have received assurances from the New York City Economic Development Corporation and the Manhattan Borough President that the city will not move forward with the approval ...
Newly unveiled plans for a 50-story hotel and apartment tower on the South Street Seaport waterfront have prompted opponents of developer Howard Hughes Corporation to organize a protest at tonight’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback